Lymphoma Clinical Trials

Showing 1021-1040 of 3,379 trials

A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma

NCT06734871

A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.

B-Cell Non-Hodgkin Lymphoma

Aibin Liang，MD，Ph.D.24 participantsStarted Dec 2024

Shanghai, Shanghai Municipality, China

RECRUITINGEARLY Phase 1

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

NCT06756321

This study is a single-center, open-label clinical trial of single-dose of CAR T-cells in subjects with relapsed/refractory hematologic malignancy.

Relapsed/refractory LymphomaRelapsed/Refractory Leukemia

Affiliated Hospital of Nantong University9 participantsStarted Sep 2023

Nantong, Jiangsu, China

Not Yet RecruitingPhase 2

Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma

NCT06757894

This is a prospective, single-arm, multicenter, phase ll clinical trial to evaluate the efficacy and safety of Zuberitamab and Bendamustine combination treatment in treatment-naïve follicular lymphoma patients.

Follicular Lymphoma (FL)

Sun Yat-sen University50 participantsStarted Feb 2025

Guangzhou, Guangdong, China

A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma

Related Searches

Chidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell Lymphoma

CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01)

Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker

Dynamic CtDNA-guided Targeted Therapy in DLBCL

The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)

Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

VHAG in Treating R/R T-ALL/LBL

Allo-HSCT vs ASCT in Adult T-LBL

Real-World Study of DLBCL With Different Genetic Subtypes

Intratumoral CAN2109 in Subjects With Solid Tumors

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma